UK markets close in 1 hour 24 minutes

Beam Therapeutics Inc. (BEAM)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.38-0.22 (-1.02%)
As of 10:06AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
377,709
377,709
60,920
51,844
24
Operating expenses
Research development
437,381
437,381
311,594
387,087
103,179
Selling general and administrative
116,813
116,813
87,805
57,222
29,605
Total operating expenses
554,194
554,194
399,399
444,309
132,784
Operating income or loss
-176,485
-176,485
-338,479
-392,465
-132,760
Total other income/expenses net
-1,352
-1,352
63,004
21,836
-62,883
Income before tax
-131,161
-131,161
-260,178
-370,638
-194,592
Income tax expense
1,366
1,366
3,410
0
0
Income from continuing operations
-132,527
-132,527
-289,088
-370,638
-194,592
Net income
-132,527
-132,527
-289,088
-370,638
-194,592
Net income available to common shareholders
-132,527
-132,527
-289,088
-370,638
-195,869
Basic EPS
-4.17
-1.72
-4.13
-5.77
-4.19
Diluted EPS
-4.17
-1.72
-4.13
-5.77
-4.19
Basic average shares
74,623
77,152
70,015
64,228
46,733
Diluted average shares
74,623
77,152
70,015
64,228
46,733